Chinese Journal of Tissue Engineering Research ›› 2014, Vol. 18 ›› Issue (5): 705-711.doi: 10.3969/j.issn.2095-4344.2014.05.009

Previous Articles     Next Articles

Artificial chordae transplantation and saddle ring annuloplasty in the treatment of degenerative mitral regurgitation

Han Jin-song, Wang Hui-shan, Yin Zong-tao, Han Hong-guang, Song Heng-chang   

  1. Department of Cardiovascular Surgery, General Hospital of Shenyang Military Area Command, Shenyang 110016, Liaoning Province, China
  • Revised:2013-11-15 Online:2014-01-29 Published:2014-01-29
  • Contact: Wang Hui-shan, M.D., Chief physician, Professor, Doctoral supervisor, Department of Cardiovascular Surgery, General Hospital of Shenyang Military Area Command, Shenyang 110016, Liaoning Province, China
  • About author:Han Jin-song, Studying for doctorate, Associate chief physician, Department of Cardiovascular Surgery, General Hospital of Shenyang Military Area Command, Shenyang 110016, Liaoning Province, China

Abstract:

BACKGROUND: Artificial chordae transplantation and saddle ring annuloplasty are the key steps in mitral valvuloplasty. However, there are no large-size studies addressing the safety, validity and efficacy of these treatments in China.

OBJECTIVE: To summarize the efficacy and safety of artificial chordae transplantation and saddle ring annuloplasty in the treatment of degenerative mitral regurgitation.
METHODS: Eighty-five patients with degenerative mitral regurgitation underwent mitral valve repair with artificial chordae (Gore-Tex sutures) transplantation and saddle ring (SJMTM rigid saddle-shaped) annuloplasty from January 2009 to May 2013 in General Hospital of Shenyang Area Military Command, China. Operative technique included simple artificial chordae transplantation in 41 cases, artificial chordae transplantation plus quadrangular resection of the posterior leaflet in 22 cases, artificial chordae transplantation plus quadrangular resection of the posterior leaflet and sliding technique in 23 cases. All cases received saddle ring annuloplasty.

RESULTS AND CONCLUSION: Follow-up after treatment was done among 78 patients for 6 months to 4 years, with a follow-up rate of 91.7% (78/85). Among the 78 cases, one case died of cerebral infarction after 13 months, one died from accident, and the remaining 76 were alive. According to the evaluation of cardiac function (NYHA), 59 cases were in grade I and 17 cases were in grade II. Color ultrasound displayed that, no regurgitation was found in 67 cases, and mild regurgitation in 9 cases. The echocardiography showed that postoperative left atrium diameter (P < 0.05 or P < 0.01), left ventricular end-diastolic diameter (P < 0.05 or P < 0.01), left ventricular end-systolic diameter (P < 0.05 or P < 0.01), and the ratio of regurgitation beam area and left atrial area (P < 0.05 or P < 0.01), mean pulmonary artery pressure (P < 0.05 or P < 0.01) were significantly decreased compared with that before operation. Ejection fraction was significantly increased after operation (P < 0.05 or P < 0.01). No systolic anterior motion occurred. The postoperative complications included sinus bradycardia in 12 cases and paroxysmal supraventricular tachycardia in 25 cases, late cardiac tamponade in 1 case at 1 week postoperatively, and pacemarker implantation in 1 case (who exhibited bradycardia-tachycardia syndrome before operation). There was no ring rupture, ring avulsion, hemolysis, left ventricular outflow tract infarction and artificial chordae rupture or splitting. No cases needed reoperation on valve replacement. Application of artificial chordae transplantation and saddle ring annuloplasty is a safe and effective means for treating degenerative mitral regurgitation, with excellent midterm outcomes.



中国组织工程研究
杂志出版内容重点:肾移植肝移植移植;心脏移植;组织移植;皮肤移植;皮瓣移植;血管移植;器官移植组织工程


全文链接:

Key words:  transplantation, mitral valve regurgitation, mitral valve annuloplasty, chordae tendineae

CLC Number: